SiRNA targeting of Trop2 suppresses the proliferation and invasion of lung adenocarcinoma H460 cells

Experimental and Therapeutic Medicine

Volumn 10, Issue 2, 2015, Pages 429-434

  Gao, Xiao Yan ^a   Zhu, Ye Han ^b   Zhang, Li Xin ^a   Lu, Hui Yu ^a   Jiang, Ai Gui ^a  

^a NANTONG UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Lung adenocarcinoma; Small interfering RNA; Trop2

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROP2 GENE; WESTERN BLOTTING;

EID: 84931829098     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2530     Document Type: Article

References (23)

1. Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83: 584-594, 2008.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250, 2005.
4. Yamamoto C, Basaki Y, Kawahara A, et al: Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations. Cancer Res 70: 8715-8725, 2010.
5. Jiang A, Gao X, Zhang D, Zhang L and Lu H: Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma. Oncol Lett 6: 375-380, 2013.
6. Gelsomino F, Rossi G and Tiseo M: Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements. J Thorac Dis 7: 220-223, 2015.
7. Thomas A, Lee JH, Abdullaev Z, et al: Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer. J Thorac Oncol 9: 567-571, 2014.
8. Calabrese G, Crescenzi C, Morizio E, Palka G, Guerra E and Alberti S: Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet Cell Genet 92: 164-165, 2001.
9. Taylor JT, Zeng XB, Pottle JE, et al: Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol 14: 4984-4991, 2008.
10. Nelsen CJ, Kuriyama R, Hirsch B, et al: Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy. J Biol Chem 280: 768-776, 2005.
11. Cubas R, Zhang S, Li M, Chen C and Yao Q: Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 9: 253, 2010.
12. Jiang HF and Bo JJ: Trophoblastic cell surface protein 2 and tumor. Guo Ji Zhong Liu Xue Za Zhi 39: 96-98, 2012 (In Chinese).
13. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K and Mori M: Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12: 3057-3063, 2006.
14. Fong D, Spizzo G, Gostner JM, et al: TROP2: A novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 21: 186-191, 2008.
15. Fong D, Moser P, Krammel C, et al: High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 99: 1290-1295, 2008.
16. Kobayashi H, Minami Y, Anami Y, Kondou Y, Iijima T, Kano J, Morishita Y, Tsuta K, Hayashi S and Noguchi M; IASLC International Staging Committee: Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma. Virchows Arch 457: 69-76, 2010.
17. Pak MG, Shin DH, Lee CH and Lee MK: Significance of EpCAM and TROP2 expression in non-small cell lung cancer. World J Surg Oncol 10: 53, 2012.
18. Gu YP, Zhao YG, Zhu YB, Zhang GB and Huang JA: Primary study of expression of TROP-2 in human pulmonary adenocarcinoma and cell lines. Zhong Liu Fang Zhi Za Zhi 20: 342-346, 2013 (In Chinese).
19. Jiang AG, Lu HY, Zhang DG, Zhang LX and Gao XY: Short hairpin RNA targeting AKT1 and PI3K/p85 suppresses the proliferation and self renewal of lung cancer stem cells. Mol Med Rep 12: 363-370, 2015.
20. Shen YH, Godlewski J, Bronisz A, et al: Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding. Mol Biol Cell 14: 4721-4733, 2003.
21. Tong XD, Liu HX, Zhao HR, et al: The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi 28: 741-745, 2006 (In Chinese).
22. Lebeau A, Unholzer A, Amann G, et al: EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 79: 187-198, 2003.
23. Martin MD and Matrisian LM: The other side of MMPs: Protective roles in tumor progression. Cancer Metastasis Rev 26: 717-724, 2007.